{"id":1043306,"date":"2026-09-08T00:01:02","date_gmt":"2026-09-08T00:01:02","guid":{"rendered":"https:\/\/pbsa.com.br\/"},"modified":"2026-09-07T23:48:35","modified_gmt":"2026-09-07T23:48:35","slug":"resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas","status":"publish","type":"post","link":"https:\/\/pbsa.com.br\/es\/resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas\/","title":{"rendered":"Resolu\u00e7\u00e3o CFM n\u00ba 2.464\/2026 e a regulamenta\u00e7\u00e3o do uso de PRP em condi\u00e7\u00f5es osteomusculares espec\u00edficas"},"content":{"rendered":"<p>{&#8220;main-title&#8221;:{&#8220;component&#8221;:&#8221;hc_title&#8221;,&#8221;id&#8221;:&#8221;main-title&#8221;,&#8221;title&#8221;:&#8221;&#8221;,&#8221;subtitle&#8221;:&#8221;&#8221;,&#8221;title_content&#8221;:{&#8220;component&#8221;:&#8221;hc_title_base&#8221;,&#8221;id&#8221;:&#8221;title-base&#8221;,&#8221;image&#8221;:&#8221;&#8221;,&#8221;breadcrumbs&#8221;:true,&#8221;light&#8221;:false,&#8221;alignment&#8221;:&#8221;&#8221;}},&#8221;section_5ZtkF&#8221;:{&#8220;component&#8221;:&#8221;hc_section&#8221;,&#8221;id&#8221;:&#8221;section_5ZtkF&#8221;,&#8221;section_width&#8221;:&#8221;&#8221;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;vertical_row&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;section_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_I2OVM&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_image&#8221;,&#8221;id&#8221;:&#8221;zcRRU&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;image&#8221;:&#8221;https:\/\/pbsa.com.br\/wp-content\/uploads\/2026\/09\/Foto-Newsletter-Plasma-1024&#215;576.webp|1080|1920|1043307&#8243;,&#8221;alt&#8221;:&#8221;&#8221;,&#8221;thumb_size&#8221;:&#8221;large&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_S50IU&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_space&#8221;,&#8221;id&#8221;:&#8221;VD9eH&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;size&#8221;:&#8221;space-sm&#8221;,&#8221;height&#8221;:&#8221;&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_60EZz&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_pt_post_informations&#8221;,&#8221;id&#8221;:&#8221;Hm3o2&#8243;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;post_type_slug&#8221;:&#8221;&#8221;,&#8221;position&#8221;:&#8221;align-left&#8221;,&#8221;date&#8221;:true,&#8221;categories&#8221;:true,&#8221;author&#8221;:false}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_6cQwH&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;no-margin &#8220;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;Z3aNa&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;A publica\u00e7\u00e3o da Resolu\u00e7\u00e3o CFM n\u00ba 2.464, de 2 de julho de 2026, representa relevante atualiza\u00e7\u00e3o do tratamento normativo conferido ao plasma rico em plaquetas (PRP) no \u00e2mbito da pr\u00e1tica m\u00e9dica brasileira. Sob a perspectiva de defesa da atua\u00e7\u00e3o m\u00e9dica respons\u00e1vel, a norma possui especial import\u00e2ncia porque supera o regime anterior de restri\u00e7\u00e3o puramente experimental e passa a admitir, em hip\u00f3teses delimitadas, o uso do PRP como procedimento m\u00e9dico adjuvante, desde que observados crit\u00e9rios t\u00e9cnicos, cl\u00ednicos, sanit\u00e1rios e \u00e9ticos expressamente previstos.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;iZJpu&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;O primeiro ponto que merece destaque \u00e9 que a resolu\u00e7\u00e3o n\u00e3o promove qualquer liberaliza\u00e7\u00e3o irrestrita da t\u00e9cnica. Ao contr\u00e1rio, o ato normativo adota uma l\u00f3gica de autoriza\u00e7\u00e3o restrita, condicionada e juridicamente estruturada, limitando o emprego do PRP \u00e0s seguintes condi\u00e7\u00f5es osteomusculares: <b>osteoartrite de joelho, discopatia lombar, epicondilite lateral do cotovelo e reparo meniscal<\/b>. Al\u00e9m disso, o pr\u00f3prio texto normativo ressalva, que o PRP n\u00e3o substitui o tratamento cl\u00ednico, reabilitacional, intervencionista ou cir\u00fargico indicado para cada caso, preservando-se, assim, a autonomia t\u00e9cnica do m\u00e9dico e a centralidade do ju\u00edzo cl\u00ednico individualizado.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;dEnP2&#8243;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Outro aspecto de elevada relev\u00e2ncia consiste na defini\u00e7\u00e3o regulat\u00f3ria do PRP como produto biol\u00f3gico aut\u00f3logo, derivado do sangue perif\u00e9rico do pr\u00f3prio paciente e submetido exclusivamente a manipula\u00e7\u00e3o m\u00ednima. Essa delimita\u00e7\u00e3o n\u00e3o \u00e9 meramente conceitual. Ela cumpre fun\u00e7\u00e3o jur\u00eddica e sanit\u00e1ria decisiva, na medida em que separa o PRP de outros produtos biol\u00f3gicos ou celulares sujeitos a regime regulat\u00f3rio diverso, al\u00e9m de refor\u00e7ar a necessidade de rastreabilidade, controle t\u00e9cnico e observ\u00e2ncia das normas sanit\u00e1rias aplic\u00e1veis. Nessa linha, a resolu\u00e7\u00e3o alinha-se \u00e0 orienta\u00e7\u00e3o da Anvisa, especialmente no que se refere ao processamento adequado, ao uso preferencial de sistemas fechados, \u00e0 regularidade sanit\u00e1ria dos insumos e \u00e0 veda\u00e7\u00e3o de pr\u00e1ticas que descaracterizem a natureza aut\u00f3loga do material empregado.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;z5MAG&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Em rela\u00e7\u00e3o aos procedimentos em coluna vertebral, o regime fixado \u00e9 ainda mais rigoroso. A utiliza\u00e7\u00e3o do PRP nessa hip\u00f3tese somente \u00e9 admitida mediante diagn\u00f3stico m\u00e9dico, correla\u00e7\u00e3o cl\u00ednico-radiol\u00f3gica, realiza\u00e7\u00e3o em ambiente com estrutura de hospital-dia ou hospitalar, observ\u00e2ncia de t\u00e9cnica ass\u00e9ptica rigorosa e orienta\u00e7\u00e3o por imagem, al\u00e9m da exig\u00eancia de profissional com Registro de Qualifica\u00e7\u00e3o de Especialista compat\u00edvel. A raz\u00e3o jur\u00eddica e assistencial dessa diferencia\u00e7\u00e3o \u00e9 evidente: a maior complexidade anat\u00f4mica e o potencial de complica\u00e7\u00f5es justificam um padr\u00e3o regulat\u00f3rio mais estrito, voltado \u00e0 prote\u00e7\u00e3o do paciente e \u00e0 preserva\u00e7\u00e3o da boa pr\u00e1tica m\u00e9dica.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;Dbuki&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Tamb\u00e9m merece aten\u00e7\u00e3o o conjunto de veda\u00e7\u00f5es expressas institu\u00eddo pela resolu\u00e7\u00e3o. O texto normativo pro\u00edbe o uso do PRP como promessa de cura, garantia de resultado, regenera\u00e7\u00e3o assegurada ou substitui\u00e7\u00e3o universal de cirurgia e de outros tratamentos formalmente indicados. Veda, ainda, sua utiliza\u00e7\u00e3o em contextos cl\u00ednicos incompat\u00edveis, como infec\u00e7\u00e3o ativa no local de aplica\u00e7\u00e3o, neoplasia ativa e determinadas condi\u00e7\u00f5es hematol\u00f3gicas. Sob a \u00f3tica jur\u00eddica, essas restri\u00e7\u00f5es t\u00eam dupla fun\u00e7\u00e3o: de um lado, protegem o paciente contra expectativas infundadas e pr\u00e1ticas potencialmente abusivas; de outro, resguardam o m\u00e9dico s\u00e9rio, que atua com base em evid\u00eancia, prud\u00eancia cl\u00ednica e responsabilidade \u00e9tica, afastando a banaliza\u00e7\u00e3o comercial do procedimento.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;g8XMW&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;A resolu\u00e7\u00e3o igualmente refor\u00e7a deveres documentais e informacionais relevantes. Exige-se consentimento livre e esclarecido espec\u00edfico, com linguagem compreens\u00edvel acerca da natureza aut\u00f3loga do procedimento, de sua finalidade adjuvante, de suas limita\u00e7\u00f5es cient\u00edficas, dos riscos potenciais, da possibilidade de falha terap\u00eautica e das alternativas terap\u00eauticas existentes. Al\u00e9m disso, imp\u00f5e-se registro em prontu\u00e1rio da indica\u00e7\u00e3o cl\u00ednica, dos dados pertinentes ao preparo e \u00e0 aplica\u00e7\u00e3o do PRP, dos par\u00e2metros t\u00e9cnicos dispon\u00edveis, das intercorr\u00eancias eventualmente verificadas e da evolu\u00e7\u00e3o cl\u00ednica do paciente. Tais exig\u00eancias n\u00e3o devem ser vistas como formalidade secund\u00e1ria, mas como elementos centrais de conformidade assistencial, \u00e9tica e jur\u00eddica.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;eefEj&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Em termos pr\u00e1ticos, a Resolu\u00e7\u00e3o CFM n\u00ba 2.464\/2026 inaugura um modelo regulat\u00f3rio intermedi\u00e1rio entre a proibi\u00e7\u00e3o e a libera\u00e7\u00e3o ampla. O Conselho reconhece a evolu\u00e7\u00e3o das evid\u00eancias cient\u00edficas e admite o uso do PRP em indica\u00e7\u00f5es espec\u00edficas, mas o faz sem renunciar ao dever de controle, rastreabilidade, prud\u00eancia t\u00e9cnica e responsabiliza\u00e7\u00e3o m\u00e9dica. Para o corpo cl\u00ednico, para as cl\u00ednicas e para os estabelecimentos de sa\u00fade, a mensagem institucional \u00e9 clara: o uso do PRP \u00e9 juridicamente poss\u00edvel, por\u00e9m condicionado ao estrito cumprimento dos par\u00e2metros definidos pela norma e \u00e0 observ\u00e2ncia da medicina baseada em indica\u00e7\u00e3o precisa, documenta\u00e7\u00e3o adequada e seguran\u00e7a do paciente.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;FsBHD&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Sob a perspectiva de quem defende m\u00e9dicos, a resolu\u00e7\u00e3o tem m\u00e9rito justamente por proteger a atua\u00e7\u00e3o m\u00e9dica qualificada, afastando tanto a improvisa\u00e7\u00e3o terap\u00eautica quanto a explora\u00e7\u00e3o indevida do procedimento por agentes sem habilita\u00e7\u00e3o legal. N\u00e3o se trata de conferir salvo-conduto indiscriminado ao uso do PRP, mas de estabelecer balizas objetivas para que sua utiliza\u00e7\u00e3o ocorra dentro de um ambiente de legalidade, responsabilidade t\u00e9cnica e integridade assistencial.&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_WIvqE&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_space&#8221;,&#8221;id&#8221;:&#8221;KP8kY&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;size&#8221;:&#8221;space-sm&#8221;,&#8221;height&#8221;:&#8221;&#8221;},{&#8220;component&#8221;:&#8221;hc_pt_post_informations&#8221;,&#8221;id&#8221;:&#8221;w6hjf&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;post_type_slug&#8221;:&#8221;&#8221;,&#8221;position&#8221;:&#8221;align-left&#8221;,&#8221;date&#8221;:false,&#8221;categories&#8221;:false,&#8221;author&#8221;:true},{&#8220;component&#8221;:&#8221;hc_space&#8221;,&#8221;id&#8221;:&#8221;gT5Xl&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;size&#8221;:&#8221;space&#8221;,&#8221;height&#8221;:&#8221;&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_CPZ7N&#8221;,&#8221;column_width&#8221;:&#8221;col-md-6&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_social_share_buttons&#8221;,&#8221;id&#8221;:&#8221;o6DpD&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;style&#8221;:&#8221;icon-links-button&#8221;,&#8221;size&#8221;:&#8221;&#8221;,&#8221;alignment&#8221;:&#8221;&#8221;,&#8221;type&#8221;:&#8221;&#8221;,&#8221;social_colors&#8221;:false,&#8221;fb&#8221;:true,&#8221;fb_link&#8221;:&#8221;https:\/\/pbsa.com.br\/resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas\/&#8221;,&#8221;tw&#8221;:true,&#8221;tw_link&#8221;:&#8221;https:\/\/pbsa.com.br\/resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas\/&#8221;,&#8221;pi&#8221;:false,&#8221;pi_link&#8221;:&#8221;&#8221;,&#8221;li&#8221;:true,&#8221;li_link&#8221;:&#8221;https:\/\/pbsa.com.br\/resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas\/&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_WO9WM&#8221;,&#8221;column_width&#8221;:&#8221;col-md-6&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_pt_navigation&#8221;,&#8221;id&#8221;:&#8221;k2nsR&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;post_type_slug&#8221;:&#8221;post&#8221;,&#8221;archive_link&#8221;:&#8221;&#8221;,&#8221;previous_text&#8221;:&#8221;Anterior&#8221;,&#8221;next_text&#8221;:&#8221;Pr\u00f3ximo&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_W0RUP&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[]}],&#8221;section_settings&#8221;:{&#8220;component&#8221;:&#8221;hc_section_image&#8221;,&#8221;id&#8221;:&#8221;section-image&#8221;,&#8221;image&#8221;:&#8221;&#8221;,&#8221;full_screen&#8221;:false,&#8221;full_screen_height&#8221;:&#8221;&#8221;,&#8221;parallax&#8221;:false,&#8221;bleed&#8221;:&#8221;&#8221;,&#8221;ken_burn&#8221;:&#8221;&#8221;,&#8221;bg_pos&#8221;:&#8221;&#8221;}},&#8221;scripts&#8221;:{},&#8221;css&#8221;:{},&#8221;css_page&#8221;:&#8221;&#8221;,&#8221;template_setting&#8221;:{},&#8221;template_setting_top&#8221;:{},&#8221;page_setting&#8221;:{&#8220;settings&#8221;:[&#8220;lock-mode-off&#8221;]},&#8221;post_type_setting&#8221;:{&#8220;settings&#8221;:{&#8220;image&#8221;:&#8221;https:\/\/pbsa.com.br\/wp-content\/uploads\/2026\/09\/Foto-Newsletter-Plasma-1024&#215;576.webp|1080|1920|1043307&#8243;,&#8221;excerpt&#8221;:&#8221;A publica\u00e7\u00e3o da Resolu\u00e7\u00e3o CFM n\u00ba 2.464, de 2 de julho de 2026, representa relevante&#8230;&#8221;,&#8221;extra_1&#8243;:&#8221;&#8221;,&#8221;extra_2&#8243;:&#8221;&#8221;,&#8221;icon&#8221;:{&#8220;icon&#8221;:&#8221;&#8221;,&#8221;icon_style&#8221;:&#8221;&#8221;,&#8221;icon_image&#8221;:&#8221;&#8221;}}}}<\/p>\n","protected":false},"excerpt":{"rendered":"<p>{&#8220;main-title&#8221;:{&#8220;component&#8221;:&#8221;hc_title&#8221;,&#8221;id&#8221;:&#8221;main-title&#8221;,&#8221;title&#8221;:&#8221;&#8221;,&#8221;subtitle&#8221;:&#8221;&#8221;,&#8221;title_content&#8221;:{&#8220;component&#8221;:&#8221;hc_title_base&#8221;,&#8221;id&#8221;:&#8221;title-base&#8221;,&#8221;image&#8221;:&#8221;&#8221;,&#8221;breadcrumbs&#8221;:true,&#8221;light&#8221;:false,&#8221;alignment&#8221;:&#8221;&#8221;}},&#8221;section_5ZtkF&#8221;:{&#8220;component&#8221;:&#8221;hc_section&#8221;,&#8221;id&#8221;:&#8221;section_5ZtkF&#8221;,&#8221;section_width&#8221;:&#8221;&#8221;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;vertical_row&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;section_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_I2OVM&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_image&#8221;,&#8221;id&#8221;:&#8221;zcRRU&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;image&#8221;:&#8221;https:\/\/pbsa.com.br\/wp-content\/uploads\/2026\/09\/Foto-Newsletter-Plasma-1024&#215;576.webp|1080|1920|1043307&#8243;,&#8221;alt&#8221;:&#8221;&#8221;,&#8221;thumb_size&#8221;:&#8221;large&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_S50IU&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_space&#8221;,&#8221;id&#8221;:&#8221;VD9eH&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;size&#8221;:&#8221;space-sm&#8221;,&#8221;height&#8221;:&#8221;&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_60EZz&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_pt_post_informations&#8221;,&#8221;id&#8221;:&#8221;Hm3o2&#8243;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;post_type_slug&#8221;:&#8221;&#8221;,&#8221;position&#8221;:&#8221;align-left&#8221;,&#8221;date&#8221;:true,&#8221;categories&#8221;:true,&#8221;author&#8221;:false}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_6cQwH&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;no-margin &#8220;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;Z3aNa&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;A publica\u00e7\u00e3o da Resolu\u00e7\u00e3o CFM n\u00ba 2.464, de 2 de julho de 2026, representa relevante atualiza\u00e7\u00e3o do tratamento normativo conferido ao plasma rico em plaquetas (PRP) no \u00e2mbito da pr\u00e1tica m\u00e9dica brasileira. Sob a perspectiva de defesa da atua\u00e7\u00e3o m\u00e9dica respons\u00e1vel, a norma possui especial import\u00e2ncia porque supera o regime anterior de restri\u00e7\u00e3o puramente experimental e passa a admitir, em hip\u00f3teses delimitadas, o uso do PRP como procedimento m\u00e9dico adjuvante, desde que observados crit\u00e9rios t\u00e9cnicos, cl\u00ednicos, sanit\u00e1rios e \u00e9ticos expressamente previstos.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;iZJpu&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;O primeiro ponto que merece destaque \u00e9 que a resolu\u00e7\u00e3o n\u00e3o promove qualquer liberaliza\u00e7\u00e3o irrestrita da t\u00e9cnica. Ao contr\u00e1rio, o ato normativo adota uma l\u00f3gica de autoriza\u00e7\u00e3o restrita, condicionada e juridicamente estruturada, limitando o emprego do PRP \u00e0s seguintes condi\u00e7\u00f5es osteomusculares: osteoartrite de joelho, discopatia lombar, epicondilite lateral do cotovelo e reparo meniscal. Al\u00e9m disso, o pr\u00f3prio texto normativo ressalva, que o PRP n\u00e3o substitui o tratamento cl\u00ednico, reabilitacional, intervencionista ou cir\u00fargico indicado para cada caso, preservando-se, assim, a autonomia t\u00e9cnica do m\u00e9dico e a centralidade do ju\u00edzo cl\u00ednico individualizado.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;dEnP2&#8243;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Outro aspecto de elevada relev\u00e2ncia consiste na defini\u00e7\u00e3o regulat\u00f3ria do PRP como produto biol\u00f3gico aut\u00f3logo, derivado do sangue perif\u00e9rico do pr\u00f3prio paciente e submetido exclusivamente a manipula\u00e7\u00e3o m\u00ednima. Essa delimita\u00e7\u00e3o n\u00e3o \u00e9 meramente conceitual. Ela cumpre fun\u00e7\u00e3o jur\u00eddica e sanit\u00e1ria decisiva, na medida em que separa o PRP de outros produtos biol\u00f3gicos ou celulares sujeitos a regime regulat\u00f3rio diverso, al\u00e9m de refor\u00e7ar a necessidade de rastreabilidade, controle t\u00e9cnico e observ\u00e2ncia das normas sanit\u00e1rias aplic\u00e1veis. Nessa linha, a resolu\u00e7\u00e3o alinha-se \u00e0 orienta\u00e7\u00e3o da Anvisa, especialmente no que se refere ao processamento adequado, ao uso preferencial de sistemas fechados, \u00e0 regularidade sanit\u00e1ria dos insumos e \u00e0 veda\u00e7\u00e3o de pr\u00e1ticas que descaracterizem a natureza aut\u00f3loga do material empregado.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;z5MAG&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Em rela\u00e7\u00e3o aos procedimentos em coluna vertebral, o regime fixado \u00e9 ainda mais rigoroso. A utiliza\u00e7\u00e3o do PRP nessa hip\u00f3tese somente \u00e9 admitida mediante diagn\u00f3stico m\u00e9dico, correla\u00e7\u00e3o cl\u00ednico-radiol\u00f3gica, realiza\u00e7\u00e3o em ambiente com estrutura de hospital-dia ou hospitalar, observ\u00e2ncia de t\u00e9cnica ass\u00e9ptica rigorosa e orienta\u00e7\u00e3o por imagem, al\u00e9m da exig\u00eancia de profissional com Registro de Qualifica\u00e7\u00e3o de Especialista compat\u00edvel. A raz\u00e3o jur\u00eddica e assistencial dessa diferencia\u00e7\u00e3o \u00e9 evidente: a maior complexidade anat\u00f4mica e o potencial de complica\u00e7\u00f5es justificam um padr\u00e3o regulat\u00f3rio mais estrito, voltado \u00e0 prote\u00e7\u00e3o do paciente e \u00e0 preserva\u00e7\u00e3o da boa pr\u00e1tica m\u00e9dica.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;Dbuki&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Tamb\u00e9m merece aten\u00e7\u00e3o o conjunto de veda\u00e7\u00f5es expressas institu\u00eddo pela resolu\u00e7\u00e3o. O texto normativo pro\u00edbe o uso do PRP como promessa de cura, garantia de resultado, regenera\u00e7\u00e3o assegurada ou substitui\u00e7\u00e3o universal de cirurgia e de outros tratamentos formalmente indicados. Veda, ainda, sua utiliza\u00e7\u00e3o em contextos cl\u00ednicos incompat\u00edveis, como infec\u00e7\u00e3o ativa no local de aplica\u00e7\u00e3o, neoplasia ativa e determinadas condi\u00e7\u00f5es hematol\u00f3gicas. Sob a \u00f3tica jur\u00eddica, essas restri\u00e7\u00f5es t\u00eam dupla fun\u00e7\u00e3o: de um lado, protegem o paciente contra expectativas infundadas e pr\u00e1ticas potencialmente abusivas; de outro, resguardam o m\u00e9dico s\u00e9rio, que atua com base em evid\u00eancia, prud\u00eancia cl\u00ednica e responsabilidade \u00e9tica, afastando a banaliza\u00e7\u00e3o comercial do procedimento.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;g8XMW&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;A resolu\u00e7\u00e3o igualmente refor\u00e7a deveres documentais e informacionais relevantes. Exige-se consentimento livre e esclarecido espec\u00edfico, com linguagem compreens\u00edvel acerca da natureza aut\u00f3loga do procedimento, de sua finalidade adjuvante, de suas limita\u00e7\u00f5es cient\u00edficas, dos riscos potenciais, da possibilidade de falha terap\u00eautica e das alternativas terap\u00eauticas existentes. Al\u00e9m disso, imp\u00f5e-se registro em prontu\u00e1rio da indica\u00e7\u00e3o cl\u00ednica, dos dados pertinentes ao preparo e \u00e0 aplica\u00e7\u00e3o do PRP, dos par\u00e2metros t\u00e9cnicos dispon\u00edveis, das intercorr\u00eancias eventualmente verificadas e da evolu\u00e7\u00e3o cl\u00ednica do paciente. Tais exig\u00eancias n\u00e3o devem ser vistas como formalidade secund\u00e1ria, mas como elementos centrais de conformidade assistencial, \u00e9tica e jur\u00eddica.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;eefEj&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Em termos pr\u00e1ticos, a Resolu\u00e7\u00e3o CFM n\u00ba 2.464\/2026 inaugura um modelo regulat\u00f3rio intermedi\u00e1rio entre a proibi\u00e7\u00e3o e a libera\u00e7\u00e3o ampla. O Conselho reconhece a evolu\u00e7\u00e3o das evid\u00eancias cient\u00edficas e admite o uso do PRP em indica\u00e7\u00f5es espec\u00edficas, mas o faz sem renunciar ao dever de controle, rastreabilidade, prud\u00eancia t\u00e9cnica e responsabiliza\u00e7\u00e3o m\u00e9dica. Para o corpo cl\u00ednico, para as cl\u00ednicas e para os estabelecimentos de sa\u00fade, a mensagem institucional \u00e9 clara: o uso do PRP \u00e9 juridicamente poss\u00edvel, por\u00e9m condicionado ao estrito cumprimento dos par\u00e2metros definidos pela norma e \u00e0 observ\u00e2ncia da medicina baseada em indica\u00e7\u00e3o precisa, documenta\u00e7\u00e3o adequada e seguran\u00e7a do paciente.&#8221;},{&#8220;component&#8221;:&#8221;hc_text_block&#8221;,&#8221;id&#8221;:&#8221;FsBHD&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;content&#8221;:&#8221;Sob a perspectiva de quem defende m\u00e9dicos, a resolu\u00e7\u00e3o tem m\u00e9rito justamente por proteger a atua\u00e7\u00e3o m\u00e9dica qualificada, afastando tanto a improvisa\u00e7\u00e3o terap\u00eautica quanto a explora\u00e7\u00e3o indevida do procedimento por agentes sem habilita\u00e7\u00e3o legal. N\u00e3o se trata de conferir salvo-conduto indiscriminado ao uso do PRP, mas de estabelecer balizas objetivas para que sua utiliza\u00e7\u00e3o ocorra dentro de um ambiente de legalidade, responsabilidade t\u00e9cnica e integridade assistencial.&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_WIvqE&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_space&#8221;,&#8221;id&#8221;:&#8221;KP8kY&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;size&#8221;:&#8221;space-sm&#8221;,&#8221;height&#8221;:&#8221;&#8221;},{&#8220;component&#8221;:&#8221;hc_pt_post_informations&#8221;,&#8221;id&#8221;:&#8221;w6hjf&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;post_type_slug&#8221;:&#8221;&#8221;,&#8221;position&#8221;:&#8221;align-left&#8221;,&#8221;date&#8221;:false,&#8221;categories&#8221;:false,&#8221;author&#8221;:true},{&#8220;component&#8221;:&#8221;hc_space&#8221;,&#8221;id&#8221;:&#8221;gT5Xl&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;size&#8221;:&#8221;space&#8221;,&#8221;height&#8221;:&#8221;&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_CPZ7N&#8221;,&#8221;column_width&#8221;:&#8221;col-md-6&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_social_share_buttons&#8221;,&#8221;id&#8221;:&#8221;o6DpD&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;style&#8221;:&#8221;icon-links-button&#8221;,&#8221;size&#8221;:&#8221;&#8221;,&#8221;alignment&#8221;:&#8221;&#8221;,&#8221;type&#8221;:&#8221;&#8221;,&#8221;social_colors&#8221;:false,&#8221;fb&#8221;:true,&#8221;fb_link&#8221;:&#8221;https:\/\/pbsa.com.br\/resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas\/&#8221;,&#8221;tw&#8221;:true,&#8221;tw_link&#8221;:&#8221;https:\/\/pbsa.com.br\/resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas\/&#8221;,&#8221;pi&#8221;:false,&#8221;pi_link&#8221;:&#8221;&#8221;,&#8221;li&#8221;:true,&#8221;li_link&#8221;:&#8221;https:\/\/pbsa.com.br\/resolucao-cfm-no-2-464-2026-e-a-regulamentacao-do-uso-de-prp-em-condicoes-osteomusculares-especificas\/&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_WO9WM&#8221;,&#8221;column_width&#8221;:&#8221;col-md-6&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[{&#8220;component&#8221;:&#8221;hc_pt_navigation&#8221;,&#8221;id&#8221;:&#8221;k2nsR&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;post_type_slug&#8221;:&#8221;post&#8221;,&#8221;archive_link&#8221;:&#8221;&#8221;,&#8221;previous_text&#8221;:&#8221;Anterior&#8221;,&#8221;next_text&#8221;:&#8221;Pr\u00f3ximo&#8221;}]},{&#8220;component&#8221;:&#8221;hc_column&#8221;,&#8221;id&#8221;:&#8221;column_W0RUP&#8221;,&#8221;column_width&#8221;:&#8221;col-md-12&#8243;,&#8221;animation&#8221;:&#8221;&#8221;,&#8221;animation_time&#8221;:&#8221;&#8221;,&#8221;timeline_animation&#8221;:&#8221;&#8221;,&#8221;timeline_delay&#8221;:&#8221;&#8221;,&#8221;timeline_order&#8221;:&#8221;&#8221;,&#8221;css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_classes&#8221;:&#8221;&#8221;,&#8221;custom_css_styles&#8221;:&#8221;&#8221;,&#8221;main_content&#8221;:[]}],&#8221;section_settings&#8221;:{&#8220;component&#8221;:&#8221;hc_section_image&#8221;,&#8221;id&#8221;:&#8221;section-image&#8221;,&#8221;image&#8221;:&#8221;&#8221;,&#8221;full_screen&#8221;:false,&#8221;full_screen_height&#8221;:&#8221;&#8221;,&#8221;parallax&#8221;:false,&#8221;bleed&#8221;:&#8221;&#8221;,&#8221;ken_burn&#8221;:&#8221;&#8221;,&#8221;bg_pos&#8221;:&#8221;&#8221;}},&#8221;scripts&#8221;:{},&#8221;css&#8221;:{},&#8221;css_page&#8221;:&#8221;&#8221;,&#8221;template_setting&#8221;:{},&#8221;template_setting_top&#8221;:{},&#8221;page_setting&#8221;:{&#8220;settings&#8221;:[&#8220;lock-mode-off&#8221;]},&#8221;post_type_setting&#8221;:{&#8220;settings&#8221;:{&#8220;image&#8221;:&#8221;https:\/\/pbsa.com.br\/wp-content\/uploads\/2026\/09\/Foto-Newsletter-Plasma-1024&#215;576.webp|1080|1920|1043307&#8243;,&#8221;excerpt&#8221;:&#8221;A publica\u00e7\u00e3o da Resolu\u00e7\u00e3o CFM n\u00ba 2.464, de 2 de julho de 2026, representa relevante&#8230;&#8221;,&#8221;extra_1&#8243;:&#8221;&#8221;,&#8221;extra_2&#8243;:&#8221;&#8221;,&#8221;icon&#8221;:{&#8220;icon&#8221;:&#8221;&#8221;,&#8221;icon_style&#8221;:&#8221;&#8221;,&#8221;icon_image&#8221;:&#8221;&#8221;}}}}<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","_joinchat":[],"footnotes":""},"categories":[12,14],"tags":[86,87,80],"coauthors":[83],"class_list":["post-1043306","post","type-post","status-publish","format-standard","hentry","category-advocacia-preventiva","category-clinicas-medicas","tag-juridico","tag-legislacao","tag-sociedades-medicas"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/posts\/1043306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/comments?post=1043306"}],"version-history":[{"count":4,"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/posts\/1043306\/revisions"}],"predecessor-version":[{"id":1043309,"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/posts\/1043306\/revisions\/1043309"}],"wp:attachment":[{"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/media?parent=1043306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/categories?post=1043306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/tags?post=1043306"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/pbsa.com.br\/es\/wp-json\/wp\/v2\/coauthors?post=1043306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}